1116 related articles for article (PubMed ID: 25550161)
1. Transmission of atherosclerosis susceptibility with gut microbial transplantation.
Gregory JC; Buffa JA; Org E; Wang Z; Levison BS; Zhu W; Wagner MA; Bennett BJ; Li L; DiDonato JA; Lusis AJ; Hazen SL
J Biol Chem; 2015 Feb; 290(9):5647-60. PubMed ID: 25550161
[TBL] [Abstract][Full Text] [Related]
2. Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice.
Ramezani A; Nolin TD; Barrows IR; Serrano MG; Buck GA; Regunathan-Shenk R; West RE; Latham PS; Amdur R; Raj DS
Sci Rep; 2018 Oct; 8(1):14752. PubMed ID: 30283097
[TBL] [Abstract][Full Text] [Related]
3. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
[TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.
Qiu L; Tao X; Xiong H; Yu J; Wei H
Food Funct; 2018 Aug; 9(8):4299-4309. PubMed ID: 30039147
[TBL] [Abstract][Full Text] [Related]
6. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.
Wang Z; Roberts AB; Buffa JA; Levison BS; Zhu W; Org E; Gu X; Huang Y; Zamanian-Daryoush M; Culley MK; DiDonato AJ; Fu X; Hazen JE; Krajcik D; DiDonato JA; Lusis AJ; Hazen SL
Cell; 2015 Dec; 163(7):1585-95. PubMed ID: 26687352
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.
Luo T; Guo Z; Liu D; Guo Z; Wu Q; Li Q; Lin R; Chen P; Ou C; Chen M
Gut Microbes; 2022; 14(1):2077602. PubMed ID: 35613310
[TBL] [Abstract][Full Text] [Related]
8. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
Koay YC; Chen YC; Wali JA; Luk AWS; Li M; Doma H; Reimark R; Zaldivia MTK; Habtom HT; Franks AE; Fusco-Allison G; Yang J; Holmes A; Simpson SJ; Peter K; O'Sullivan JF
Cardiovasc Res; 2021 Jan; 117(2):435-449. PubMed ID: 32267921
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
12. Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.
Su C; Li X; Yang Y; Du Y; Zhang X; Wang L; Hong B
Nutr Diabetes; 2021 Jul; 11(1):27. PubMed ID: 34389700
[TBL] [Abstract][Full Text] [Related]
13. Dietary Choline or Trimethylamine N-oxide Supplementation Does Not Influence Atherosclerosis Development in Ldlr-/- and Apoe-/- Male Mice.
Aldana-Hernández P; Leonard KA; Zhao YY; Curtis JM; Field CJ; Jacobs RL
J Nutr; 2020 Feb; 150(2):249-255. PubMed ID: 31529091
[TBL] [Abstract][Full Text] [Related]
14. Blueberry intervention mitigates detrimental microbial metabolite trimethylamine N-oxide by modulating gut microbes.
Satheesh Babu AK; Petersen C; Iglesias-Carres L; Paz HA; Wankhade UD; Neilson AP; Anandh Babu PV
Biofactors; 2024; 50(2):392-404. PubMed ID: 37921575
[TBL] [Abstract][Full Text] [Related]
15. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Wang Z; Klipfell E; Bennett BJ; Koeth R; Levison BS; Dugar B; Feldstein AE; Britt EB; Fu X; Chung YM; Wu Y; Schauer P; Smith JD; Allayee H; Tang WH; DiDonato JA; Lusis AJ; Hazen SL
Nature; 2011 Apr; 472(7341):57-63. PubMed ID: 21475195
[TBL] [Abstract][Full Text] [Related]
16. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
[TBL] [Abstract][Full Text] [Related]
17. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL
Nat Med; 2013 May; 19(5):576-85. PubMed ID: 23563705
[TBL] [Abstract][Full Text] [Related]
18. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.
Wang X; Li X; Dong Y
Biomed Res Int; 2020; 2020():9896743. PubMed ID: 33083493
[TBL] [Abstract][Full Text] [Related]
20. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.
Koeth RA; Levison BS; Culley MK; Buffa JA; Wang Z; Gregory JC; Org E; Wu Y; Li L; Smith JD; Tang WHW; DiDonato JA; Lusis AJ; Hazen SL
Cell Metab; 2014 Nov; 20(5):799-812. PubMed ID: 25440057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
